BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BOPA - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.bopa.org.uk
X-WR-CALDESC:Events for BOPA
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210915
DTEND;VALUE=DATE:20210917
DTSTAMP:20210813T104439Z
CREATED:20190819T070646Z
LAST-MODIFIED:20210813T104439Z
UID:4522-1631664000-1631836799@www.bopa.org.uk
SUMMARY:Oncology Convention 2021
DESCRIPTION:  \nBOPA are delighted to be partnered with Oncology Convention for 2021. Taking place at the NEC\, Birmingham 15th & 16th September. \nThe speaker agenda has just been released and we’re happy to say that BOPA members can receive free CPD education with your registration. \n \nExpect talks on dynamic electro-enhance chemotherapy and lifestyle strategies after cancer with industry-leading exhibitors such as Bioscientifica and My Personal Therapeutics showcasing their latest technology. \n \nFollow the link below to register for your free ticket. We hope to see you there! \nRegister here \n 
URL:https://www.bopa.org.uk/event/oncology-convention-2019/
LOCATION:NEC Birmingham\, United Kingdom
ATTACH;FMTTYPE=image/png:https://www.bopa.org.uk/wp-content/uploads/2019/08/Oncology-logo.png
ORGANIZER;CN="Prysm Group":MAILTO:tegan.nichols@prysmgroup.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210915T190000
DTEND;TZID=UTC:20210915T203000
DTSTAMP:20210804T150213Z
CREATED:20210803T113941Z
LAST-MODIFIED:20210804T150213Z
UID:14839-1631732400-1631737800@www.bopa.org.uk
SUMMARY:My Research - Session 5: Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation in collaboration with COSACPG
DESCRIPTION:Session 5 (Wednesday 15th September at 19:00 BST) in Collaboration with COSACPG\n  \n \n  \nWe would like to invite you to join our  ‘My Research’ sessions. These sessions are delivered by members that have undertaken an audit or evaluation. They will spend 10 minutes describing their career pathway and the next 10 minutes about the research methods that they used. There will be time for detailed questions following the talk. These sessions will enable members to learn about quantitative and qualitative methods and the learning may guide and help you in your future projects. We also hope that this will be a good opportunity to learn about different career pathways in cancer pharmacy. \n  \nThe session will be delivered by: Julian Lindsay \n \nJulian Lindsay (BPharm\, MClinPharm\, PhD candidate) is a Bone Marrow Transplant (BMT) Pharmacist at Royal North Shore Hospital in Sydney\, Australia and a research fellow and PhD candidate at the National Center for Infection in Cancer (NCIC) at the Peter MacCallum Cancer Centre in Melbourne\, Australia. His research interest is prevention of infections in patients with blood cancers and those undergoing bone marrow transplants including cytomegalovirus\, Epstein-barr virus and invasive fungal infections. He will be conducting research full time in Seattle\, USA\, at The Fred Hutchinson Cancer Research Centre\, in conjunction with the Peter MacCallum Cancer Centre in Melbourne\, Australia. The research aims to address the critical knowledge gaps related to the optimization of antifungal prophylaxis\, involving large scale clinical studies of patient outcomes when using new antifungal medications\, as well as optimisation of antifungal dosing using pharmacogenomic testing to improve outcomes. \n  \n  \n  \n  \n  \nThe session will be chaired by: Nick Duncan \n \nNick is an Academic Practitioner in the School of Pharmacy at the University of Birmingham and Consultant Haematology Pharmacist at University Hospitals Birmingham NHS Foundation Trust\, UK. He qualified as a pharmacist in 1994 and has spent most of his career to date working in oncology and haematology\, particularly in the area of haematopoietic stem cell transplantation. He qualified as an independent prescriber in 2010 and has an active prescribing role in a variety of haematology clinics. Areas of research interest include medicines adherence\, chronic myeloid leukaemia and antifungal stewardship. \n  \nNick is Secretary of the UK BMT Pharmacists Group – https://www.bopa.org.uk/membergroups/affiliated-groups/bmt-group/ \n  \n  \n  \nPlease Note:\n-Webinars will start at 19:00 BST and will last about 30 minutes to 1 hour \n-The Zoom link for the webinar will be sent on the day of the event around 17:30pm (if you would like the link before this time please email contact@bopa.org.uk) \n-Webinars are FREE to access for BOPA Paid and BOPA FREE Members \n-Webinars will be recorded and appear in the BOPA eLearning section of the website via this LINK \n  \n  \nPinkie\, Bastiaan and Alkesh\nBOPA Audit & Research and Education &Training Sub-Committee Chairs
URL:https://www.bopa.org.uk/event/my-research-session-5-cytomegalovirus-cmv-management-in-allogeneic-hematopoietic-cell-transplantation-in-collaboration-with-cosacpg/
LOCATION:Virtual – Online
CATEGORIES:Education and Training
ATTACH;FMTTYPE=image/png:https://www.bopa.org.uk/wp-content/uploads/2021/08/COSACPGLogo.png
END:VEVENT
END:VCALENDAR